{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "9708037", "DateCompleted": {"Year": "1998", "Month": "09", "Day": "04"}, "DateRevised": {"Year": "2019", "Month": "11", "Day": "02"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0031-6865", "JournalIssue": {"Volume": "73", "Issue": "1", "PubDate": {"Year": "1998", "Month": "Jun"}}, "Title": "Pharmaceutica acta Helvetiae", "ISOAbbreviation": "Pharm Acta Helv"}, "ArticleTitle": "Hypericum perforatum inhibits the binding of mu- and kappa-opioid receptor expressed with the Semliki Forest virus system.", "Pagination": {"StartPage": "53", "EndPage": "56", "MedlinePgn": "53-6"}, "Abstract": {"AbstractText": ["The effects of Hypericum perforatum extracts on in vitro [3H]naloxone binding to the human mu- and rat kappa-opioid receptors were studied in chinese hamster ovary (CHO) cells using the Semliki Forest virus (SFV) expression system. Binding of [3H]naloxone to the mu- and kappa-opioid receptor was inhibited in the presence of Hypericum extracts showing IC50 values of approximately 25 and 90 micrograms/ml, respectively. In contrast, extracts of Valeriana officinalis did not inhibit binding to the mu-opioid receptor. Also, single constituents of H. perforatum like the flavonoids quercetin and kaempferol and the glycosilated flavonoid quercitrin did not inhibit [3H]naloxone binding to the mu-opioid receptor up to a concentration of 10 microM. The present in vitro data may suggest a new possible mechanism for the anti-depressant effect of H. perforatum."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Dept. of Pharmaceutical Biology, University of Basel, Switzerland."}], "LastName": "Simmen", "ForeName": "U", "Initials": "U"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Schweitzer", "ForeName": "C", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Burkard", "ForeName": "W", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Schaffner", "ForeName": "W", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Lundstrom", "ForeName": "K", "Initials": "K"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Pharm Acta Helv", "NlmUniqueID": "0401134", "ISSNLinking": "0031-6865"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Receptors, Opioid, kappa"}, {"RegistryNumber": "0", "NameOfSubstance": "Receptors, Opioid, mu"}, {"RegistryNumber": "36B82AMQ7N", "NameOfSubstance": "Naloxone"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["metabolism"], "DescriptorName": "CHO Cells"}, {"QualifierName": [], "DescriptorName": "Cricetinae"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["metabolism"], "DescriptorName": "Naloxone"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": ["antagonists & inhibitors", "metabolism"], "DescriptorName": "Receptors, Opioid, kappa"}, {"QualifierName": ["antagonists & inhibitors", "metabolism"], "DescriptorName": "Receptors, Opioid, mu"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Semliki forest virus"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1998", "Month": "8", "Day": "26"}, {"Year": "1998", "Month": "8", "Day": "26", "Hour": "0", "Minute": "1"}, {"Year": "1998", "Month": "8", "Day": "26", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["9708037", "10.1016/s0031-6865(97)00049-6", "S0031686597000496"]}}]}